CARDINAL BERNARDIN CANCER CENTER, LOYOLA UNIVERSITY

芝加哥洛约拉大学枢机主教贝尔纳丁癌症中心 理查德·I·费舍尔医学博士的指导正在申请P-20癌症 中心规划助学金。该中心占地面积12.5万平方米，价值3500万美元。 英国《金融时报》提供最先进的诊所设施的设施 Loyola的所有门诊癌症护理，34个新的研究实验室 扩大基础/翻译科学研究基地，为核心提供空间 为所有全职从事癌症相关工作的教职员工提供设施和办公室 活动以及校园和学校的行政和教育空间 社区外展活动。癌症中心主任已经 负责年内所有临床和实验室空间的分配 这一设施，招聘新的研究人员，以及管理 对机构业务预算的影响。1996年，临床项目 为10,000多名患者提供了超过45,000人次的服务， 这意味着每年增长10%-15%。在过去的几年里 五年来，洛约拉附属医院有1408名患者登记 临床研究方案。该中心目前有四个独特的 研究计划：1)曼努埃尔·迪亚兹博士和 理查德·费舍尔整合了白血病的遗传和临床研究 淋巴瘤；2)凯瑟琳·奈特和马丁博士领导的癌症免疫学 KAST整合了基础和应用的肿瘤免疫学；3)皮肤癌 由Brian Nickoloff博士将基础和临床研究整合在一起 皮肤恶性肿瘤；4)癌症的原因和预防，由博士领导。 理查德·库珀、凯西·阿尔本和罗伯特·弗拉尼根罹患癌症 针对前列腺癌和乳腺癌的预防和控制措施 癌症，特别是在少数族裔社区。当前年度联邦政府 癌症中心调查人员的资金超过830万美元。这 规划拨款将是癌症中心和 将使其能够继续快速增长和发展，通过 完成剩余的11个癌症中心的必要招聘 研究教员职位，开发所需的核心设施，扩大 跨学科的教职员工会议和研讨会，并激发新的 翻译研究计划。在这笔赠款完成时， 贝尔纳丁红衣主教癌症中心计划将 成功申请P-30癌症中心支持补助金。

The Cardinal Bernardin Cancer Center of Loyola University Chicago under the direction of Richard I. Fisher, M.D. is applying for a P-20 Cancer Center Planning Grant. The Center is a 35 million dollar, 125,000 sq. ft. facility that provides state-of-the-art clinic facilities to house all of Loyola's outpatient cancer care, 34 new research laboratories to expand the basic/translational science research base, space for core facilities, offices for all faculty engaged full-time in cancer related activities, and administrative and educational space for campus and community outreach activities. The Cancer Center Director has responsibility for allocation of all clinical and laboratory space in this facility, recruitment of new research faculty, and administration of the institutional operating budget. In 1996, the clinical program served more than 10,000 patients with over 45,000 patient visits, representing an increase of 10-15 percent per year. During the last five years, Loyola affiliated hospitals had 1408 patient registrations onto clinical research protocols. The center currently has four unique Research Programs: 1) Hematologic Malignancy led by Drs. Manuel Diaz and Richard Fisher integrates genetic and clinical studies of leukemias and lymphoma; 2) Cancer Immunology led by Drs. Katherine Knight and Martin Kast integrates basic and applied tumor immunology; 3) Skin Cancer led by Dr. Brian Nickoloff integrates basic and clinical studies of cutaneous malignancies; and 4) Cancer Cause and Prevention led by Drs. Richard Cooper, Kathy Albain, and Robert Flanigan develops cancer prevention and control initiatives targeted toward prostate and breast cancer, especially in the minority communities. Current annual federal funding of Cancer Center investigators exceeds 8,300,000 dollars. This planning grant will be a critical milestone for the Cancer Center and will enable it to continue its rapid growth and development by completing necessary recruitment of the eleven remaining Cancer Center research faculty positions, developing needed core facilities, expanding interdisciplinary faculty meetings and seminars, and stimulating new translational research initiatives. At the completion of this grant, the Cardinal Bernardin Cancer Center plans to be positioned to successfully apply for a P-30 Cancer Center Support Grant.